Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »


  • Kancera
  • Karolinska Institutet Science Park
  • Banvaktsvägen 22
  • Solna , SE-171 48

Kancera AB is a biotechnology company that focuses on the development and sale of drug candidates that have the potential to cure or to stop the progression of cancer. Kancera is currently running two pharmaceutical development projects, one relating to solid tumors and one relating to leukemia. Through a subsidiary, Kancera also provides big pharma, mid-sized pharma and biotech companies with lead identification and optimization services such as high-throughput screening (HTS), fragment-based screening (FBS), assay development and medicinal chemistry.

Related To This Company